Hyperthyroidism Prevalence in China After Universal Salt Iodization

Universal salt iodization (USI) was implemented in mainland China in 1996. The prevalence of hyperthyroidism and its risk factors now require examination. Data were acquired from a nationwide Thyroid, Iodine, and Diabetes Epidemiological survey (TIDE 2015-2017) of 78,470 subjects from 31 provinces....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in endocrinology (Lausanne) 2021-05, Vol.12, p.651534-651534
Hauptverfasser:	Wang, Chuyuan, Li, Yongze, Teng, Di, Shi, Xiaoguang, Ba, Jianming, Chen, Bing, Du, Jianling, He, Lanjie, Lai, Xiaoyang, Li, Yanbo, Chi, Haiyi, Liao, Eryuan, Liu, Chao, Liu, Libin, Qin, Guijun, Qin, Yingfen, Quan, Huibiao, Shi, Bingyin, Sun, Hui, Tang, Xulei, Tong, Nanwei, Wang, Guixia, Zhang, Jin-An, Wang, Youmin, Xue, Yuanming, Yan, Li, Yang, Jing, Yang, Lihui, Yao, Yongli, Ye, Zhen, Zhang, Qiao, Zhang, Lihui, Zhu, Jun, Zhu, Mei, Shan, Zhongyan, Teng, Weiping
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies - chemistry China - epidemiology cross-sectional study Electrochemistry Endocrinology Female Graves Disease - epidemiology Graves Disease - prevention & control Graves’ disease Humans hyperthyroidism Hyperthyroidism - epidemiology Hyperthyroidism - prevention & control Iodine - therapeutic use iodine intake Luminescence Male Middle Aged Prevalence Risk Risk Factors Rural Population Sodium Chloride, Dietary Surveys and Questionnaires thyroid autoimmune antibodies Thyroid Gland - immunology Urban Population
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Universal salt iodization (USI) was implemented in mainland China in 1996. The prevalence of hyperthyroidism and its risk factors now require examination. Data were acquired from a nationwide Thyroid, Iodine, and Diabetes Epidemiological survey (TIDE 2015-2017) of 78,470 subjects from 31 provinces. Iodine status, and thyroid hormones and antibodies were measured. After two decades of USI, the prevalence of overt hyperthyroidism (OH), Graves' disease (GD), severe subclinical hyperthyroidism (severe SCH), and mild subclinical hyperthyroidism (mild SCH) in mainland China was 0.78%, 0.53%, 0.22%, and 0.22%, respectively. OH and GD prevalence were higher in women than in men (OH: 1.16% . 0.64%, P
ISSN:	1664-2392 1664-2392
DOI:	10.3389/fendo.2021.651534